Previous 10 | Next 10 |
PTC Therapeutics Appoints Experienced Healthcare Finance Strategist Pierre Gravier as Chief Financial Officer PR Newswire SOUTH PLAINFIELD, N.J. , July 17, 2023 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced the appointment of Pierre Grav...
PTC Therapeutics Announces Virtual Presentation on Phenylketonuria (PKU) and Sepiapterin PR Newswire SOUTH PLAINFIELD, N.J. , July 11, 2023 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT), announced today that the company will provide a virtual presen...
PTC Therapeutics Announces Results from MIT-E Clinical Trial of Vatiquinone for the Treatment of Mitochondrial Disease Associated Seizures PR Newswire SOUTH PLAINFIELD, N.J. , June 29, 2023 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today th...
PTC Therapeutics Shares Positive Interim Data from PIVOT-HD Clinical Trial in Huntington's Disease Patients PR Newswire - D ose-dependent lowering of blood Huntingtin (HTT) protein levels at 12 weeks - - Favorable tolerability profile with no treatment-related se...
2023-05-25 12:40:30 ET Summary I was bearish on PTC in my June 2022 note. Despite the stock having gained marginally since, I'm still expecting a downward correction in valuation. PTC Therapeutics is a rare disease specialist that earned $220m of revenues in Q123, primarily from i...
2023-05-24 14:26:51 ET Shares of Reata Pharmaceuticals ( NASDAQ: RETA ) and PTC Therapeutics ( PTCT ) moved in opposite directions on Wednesday after the latter faced a setback for vatiquinone, a Phase 3 candidate for the neuromuscular disorder Friedreich's ataxia (FA). Whil...
2023-05-24 12:53:19 ET Gainers: Minority Equality Opportunities Acquisition ( MEOA ) +176% . Enveric Biosciences ( ENVB ) +82% . QuantaSing Group ( QSG ) +61% . EpicQuest Education Group ( EEIQ ) +51% . GigaCloud Technology ( GCT ) ...
2023-05-24 10:07:34 ET Gainers: Enveric Biosciences ( ENVB ) +100% . Zura Bio ( ZURA ) +37% . Kamada ( KMDA ) +19% . Organogenesis ( ORGO ) +16% . OptimizeRx ( OPRX ) +14% . Losers: PTC Therapeutics ( PTCT ) -24% ....
2023-05-24 05:11:28 ET PTC Therapeutics ( NASDAQ: PTCT ) has decided to discontinue its preclinical and early research programs in its gene therapy platform and to reduce its workforce by ~8%. In addition, the company informed its CFO Emily Hill that her employment will be ...
PTC Therapeutics Announces Topline Results from Vatiquinone MOVE-FA Registration-Directed Trial PR Newswire - Conference call and webcast to be held at 5:00 pm EDT - SOUTH PLAINFIELD, N.J. , May 23, 2023 /PRNewswire/ -- PTC Therapeutics, Inc. (NA...
News, Short Squeeze, Breakout and More Instantly...
PTC Therapeutics Inc. Company Name:
PTCT Stock Symbol:
NASDAQ Market:
PTC Therapeutics Inc. Website:
NEW YORK CITY, NY / ACCESSWIRE / July 18, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of PTC Therapeutics, Inc. ("PTC" or "the Company") (NASDAQ:PTCT). Investors who purchased PTC securities are encouraged to obtain additional informati...
2024-07-12 10:00:03 ET Jeffrey Hung from Morgan Stanley issued a price target of $32.00 for PTCT on 2024-07-12 08:15:00. The adjusted price target was set to $32.00. At the time of the announcement, PTCT was trading at $33.2. The overall price target consensus is at $43....
CHMP Issues Negative Opinion on Translarna™ Following European Commission Request for Review PR Newswire - PTC to submit a request for re-examination - WARREN, N.J. , June 28, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announce...